| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.83▼ | 0.84▼ | 0.84▼ | 0.86▼ | 0.94▼ |
| MA10 | 0.84▼ | 0.84▼ | 0.84▼ | 0.89▼ | 0.91▼ |
| MA20 | 0.84▼ | 0.86▼ | 0.86▼ | 0.96▼ | 0.87▼ |
| MA50 | 0.86▼ | 0.87▼ | 0.89▼ | 0.89▼ | 0.86▼ |
| MA100 | 0.87▼ | 0.90▼ | 0.93▼ | 0.86▼ | 1.07▼ |
| MA200 | 0.89▼ | 0.97▼ | 0.96▼ | 0.82▲ | 0.99▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.002▼ | -0.001▼ | -0.021▼ | 0.008▲ |
| RSI | 36.605▼ | 35.889▼ | 36.275▼ | 36.492▼ | 46.547▼ |
| STOCH | 19.732▼ | 11.958▼ | 9.781▼ | 9.960▼ | 43.868 |
| WILL %R | -82.682▼ | -94.206▼ | -94.206▼ | -98.779▼ | -82.781▼ |
| CCI | -91.165 | -98.391 | -101.123▼ | -139.406▼ | -15.871 |
|
Tuesday, October 14, 2025 06:00 AM
25+ year life-sciences finance leader brings revenue-forecasting rigor, public-company controls, and capital-markets experience as Atossa prepares for commercial operations with (Z)-endoxifen SEATTLE, ...
|
|
Wednesday, October 01, 2025 06:30 AM
Veteran development leader with successful regulatory approvals record returns to lead late-stage clinical and regulatory programs to address multiple unmet clinical needs SEATTLE, Oct. 1, 2025 ...
|
|
Wednesday, September 17, 2025 05:00 AM
SEATTLE, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS; “Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing new approaches in breast cancer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/11/25 | 0.84 | 0.848 | 0.825 | 0.8275 | 365,120 |
| 04/11/25 | 0.8556 | 0.889 | 0.8401 | 0.8481 | 605,360 |
| 03/11/25 | 0.90 | 0.907 | 0.8534 | 0.8633 | 533,652 |
| 31/10/25 | 0.873 | 0.909 | 0.87 | 0.8896 | 444,513 |
| 30/10/25 | 0.865 | 0.897 | 0.86 | 0.88 | 556,490 |
| 29/10/25 | 0.9276 | 0.9355 | 0.8596 | 0.8769 | 837,454 |
| 28/10/25 | 0.943 | 0.9579 | 0.9307 | 0.9355 | 352,862 |
| 27/10/25 | 0.9332 | 0.9579 | 0.92 | 0.9432 | 559,079 |
| 24/10/25 | 0.92 | 0.9427 | 0.9103 | 0.9322 | 636,958 |
| 23/10/25 | 0.9252 | 0.9498 | 0.9003 | 0.9154 | 481,448 |
|
|
||||
|
|
||||
|
|